GHSR and atherosclerosis: An atherosclerosis model of HFD ApoE−/− mice showed both in vivo and in vitro that hexarelin, an agonist of GHSR-1a, upregulated the expression of GHSR-1a in aortae in vivo and in macrophages in vitro and had synergistic anti-atherosclerotic effects.